COVID-19: The Italian experience.
Clin Dermatol
; 39(3): 418-423, 2021.
Article
in English
| MEDLINE | ID: covidwho-1491857
ABSTRACT
Italy was among the world's earliest and most affected countries by coronavirus disease 2019 (COVID-19). We report the Italian experience with the pandemic. The dermatologic community immediately reduced any type of activities to 80% to 90% of outpatient consultations, both in public hospitals and in private offices. The Italian Society of Dermatology and Sexually Transmitted Diseases and the Italian Forensic Dermatologic Society supported the dermatologic community by reporting recommendations in newsletters (vademecum) regarding the routine management of dermatologic patients either in the hospital or private setting. We have provided an overview of the skin manifestations from the pandemic, including the consequences of the misuse of safety measures. We also have evaluated the recently developed research projects on patients treated with biologics for psoriasis, atopic dermatitis, and hidradenitis suppurativa, as well as on the registries regarding various skin diseases affected by COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Hidradenitis Suppurativa
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Clin Dermatol
Year:
2021
Document Type:
Article
Affiliation country:
J.clindermatol.2021.01.013
Similar
MEDLINE
...
LILACS
LIS